Kidney cancer incidence statistics

Coronavirus (COVID-19)

Cancer Research UK supports GPs to deliver best practice. We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of kidney cancer each year, 2016-2018 average, UK.

 

Proportion of all cases

Percentage kidney cancer is of total cancer cases, 2016-2018, UK

 

Age

Peak rate of kidney cancer cases, 2016-2018, UK

Trend over time

Change in kidney cancer incidence rates since the early 1990s, UK

 

Kidney cancer is the 7th most common cancer in the UK, accounting for 4% of all new cancer cases (2016-2018).[1-4]

In females in the UK, kidney cancer is the 10th most common cancer (3% of all new female cancer cases). In males in the UK, it is the 5th most common cancer (4% of all new male cancer cases).

37% of kidney cancer cases in the UK are in females, and 63% are in males.

Kidney cancer incidence rates (European age-standardised (AS) rate Open a glossary item) for persons are significantly higher than the UK average in Scotland, significantly lower than the UK average in Wales and similar to the UK average in all other UK constituent countries.

For kidney cancer, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.

Kidney Cancer (C64-C66, C68), Average Number of New Cases Per Year, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2016-2018

  England Scotland Wales Northern Ireland UK
Female Cases 4,073 458 247 137 4,916
Crude Rate 14.5 16.5 15.6 14.4 14.7
AS Rate 14.6 15.9 14.4 15.6 14.8
AS Rate - 95% LCL 14.4 15.1 13.4 14.1 14.5
AS Rate - 95% UCL 14.9 16.8 15.5 17.1 15.0
Male Cases 7,008 761 400 237 8,407
Crude Rate 25.5 28.8 26.0 25.8 25.8
AS Rate 29.1 31.5 26.6 31.8 29.2
AS Rate - 95% LCL 28.7 30.2 25.1 29.4 28.8
AS Rate - 95% UCL 29.5 32.8 28.1 34.1 29.6
Persons Cases 11,082 1,219 647 374 13,322
Crude Rate 19.9 22.5 20.7 20.0 20.2
AS Rate 21.3 23.0 20.1 22.9 21.5
AS Rate - 95% LCL 21.1 22.2 19.2 21.5 21.3
AS Rate - 95% UCL 21.6 23.7 21.0 24.2 21.7

95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item
 

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/, March 2021.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016-2018, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer incidence is strongly related to age, with the highest incidence rates being in older people. In the UK in 2016-2018, on average each year around a third of new cases (34%) were in people aged 75 and over.[1-4]

Age-specific incidence rates rise from around 35 to 39, steadily for females and more steeply for males. The highest rates are in in the 85 to 89 age group for females and males.

Incidence rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 90+, when the age-specific incidence rate is 2.3 times lower in females than males.

Kidney cancer (C64-C66, C68), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, UK, 2016-2018

For kidney cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/, March 2021.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016-2018, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer European age-standardised (AS) Open a glossary item incidence rates for females and males combined increased by 88% in the UK between 1993-1995 and 2016-2018.[1-4] The increase was of a similar size in females and males.

For females, kidney cancer AS incidence rates in the UK increased by 94% between 1993-1995 and 2016-2018. For males, kidney cancer AS incidence rates in the UK increased by 77% between 1993-1995 and 2016-2018.

Over the last decade in the UK (between 2006-2008 and 2016-2018), kidney cancer AS incidence rates for females and males combined increased by 29%. In females AS incidence rates increased by 28%, and in males rates increased by 26%.

Kidney Cancer (C64-C66, C68), European Age-Standardised Incidence Rates, UK, 1993 to 2018

Kidney cancer incidence rates have increased overall in most broad age groups in females and males combined in the UK since the early 1990s, but have remained stable in some.[1-4] Rates in 0-24s have remained stable, in 25-49s have increased by 99%, in 50-59s have increased by 68%, in 60-69s have increased by 68%, in 70-79s have increased by 92% and in 80+s have increased by 135%.

Kidney Cancer (C64-C66, C68), European Age-Standardised Incidence Rates per 100,000 Persons Population, By Age, UK, 1993-2018

For kidney cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/, March 2021.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2018, ICD-10 C64-C66, C68.

Last reviewed:

Most kidney cancer cases occur in the kidney, with much smaller proportions in the renal pelvis, ureter and urethra and paraurethral gland (2010-2012).[1-4]

The proportion of cases in each part is similar between males and females.[1-4]

A small proportion of cases did not have the specific part of the kidney recorded in cancer registry data, or overlapped more than one part.[1-4]

Cases and percentages may not sum due to rounding

References

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here:
    http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here:
    http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.

About this data

Data is for UK, 2010-2012, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer incidence rates are projected to rise by 26% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035.[1] This includes a larger increase for males than for females.

For males, kidney cancer European age-standardised (AS) Open a glossary item incidence rates in the UK are projected to rise by 28% between 2014 and 2035, to 44 cases per 100,000 by 2035.[1] For females, rates are projected to rise by 18% between 2014 and 2035, to 20 cases per 100,000 by 2035.[1]

Kidney cancer (C64-C66, C68), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

It is projected that 21,732 cases of kidney cancer (14,259 in males, 7,474 in females) will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C64-C66, C68

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

Kidney cancer incidence rates (European age-standardised (AS) rates Open a glossary item) in England in females are 40% higher in the most deprived quintile compared with the least, and in males are 17% higher in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 1,100 more cases of kidney cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile. Around 580 of these cases are in females, and around 510 in males.

In the text above, males and females’ excess cases do not sum to persons excess cases due to rounding

Kidney Cancer (C64-C66, C68), Estimated Average Number of Excess Cases per Year and European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C21.

Last reviewed:

Age-standardised rates for White males with kidney cancer range from 11.2 to 11.8 per 100,000. Rates for Asian males are significantly lower, ranging from 5.3 to 9.2 per 100,000 and the rates for Black males are also significantly lower, ranging from 5.9 to 10.8 per 100,000. For females there is a different pattern - the age-standardised rates for White females range from 5.7 to 6.0 per 100,000. Rates for Black females are similar, ranging from 3.0 to 6.0 per 100,000, whereas Asian females are significantly lower, ranging from 1.9 to 3.8 per 100,000.[1]

Ranges are given because of the analysis methodology used to account for missing and unknown data. For kidney cancer, 25,886 cases were identified; 21% had no known ethnicity.

References

  1. National Cancer Intelligence Network and Cancer Research UK. Cancer Incidence and Survival by Major Ethnic Group, England, 2002-2006. 2009.

About this data

Data is for UK, 2002-2006, ICD-10 C64-C66, C68.

Last reviewed:

An estimated 46,800 people who had been diagnosed with kidney cancer between 1991 and 2010 were alive in the UK at the end of 2010.[1]

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables. London: NCRAS; 2015.

About this data

Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C64-C66, C68

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.